Nuveen’s Dynavax Technologies DVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-1,910,588
| Closed | -$29.4M | – | 3248 |
|
|
2025
Q4 | $29.4M | Buy |
1,910,588
+1,528,733
| +400% | +$16.8M | 0.01% | 920 |
|
|
2025
Q3 | $3.79M | Buy |
381,855
+130,569
| +52% | +$1.36M | ﹤0.01% | 2033 |
|
|
2025
Q2 | $2.49M | Sell |
251,286
-93,207
| -27% | -$982K | ﹤0.01% | 2207 |
|
|
2025
Q1 | $4.47M | Sell |
344,493
-3,896
| -1% | -$51.6K | ﹤0.01% | 1979 |
|
|
2024
Q4 | $4.45M | Sell |
348,389
-4,123
| -1% | -$49.9K | ﹤0.01% | 2035 |
|
|
2024
Q3 | $3.93M | Hold |
352,512
| – | – | ﹤0.01% | 2100 |
|
|
2024
Q2 | $3.96M | Sell |
352,512
-378,075
| -52% | -$4.4M | ﹤0.01% | 2068 |
|
|
2024
Q1 | $9.07M | Sell |
730,587
-140,972
| -16% | -$1.84M | ﹤0.01% | 1656 |
|
|
2023
Q4 | $12.2M | Sell |
871,559
-1,102,297
| -56% | -$15.3M | ﹤0.01% | 1462 |
|
|
2023
Q3 | $29.2M | Buy |
1,973,856
+993,283
| +101% | +$14M | 0.01% | 814 |
|
|
2023
Q2 | $12.7M | Buy |
980,573
+472,331
| +93% | +$5.38M | ﹤0.01% | 1360 |
|
|
2023
Q1 | $4.99M | Sell |
508,242
-425,545
| -46% | -$4.54M | ﹤0.01% | 1890 |
|
|
2022
Q4 | $9.94M | Sell |
933,787
-489,446
| -34% | -$5.69M | ﹤0.01% | 1490 |
|
|
2022
Q3 | $14.9M | Sell |
1,423,233
-14,943
| -1% | -$195K | 0.01% | 1217 |
|
|
2022
Q2 | $18.1M | Buy |
1,438,176
+106,876
| +8% | +$1.14M | 0.01% | 1103 |
|
|
2022
Q1 | $15.2M | Sell |
1,331,300
-41,201
| -3% | -$500K | ﹤0.01% | 1364 |
|
|
2021
Q4 | $19.3M | Buy |
1,372,501
+334,050
| +32% | +$5.5M | 0.01% | 1254 |
|
|
2021
Q3 | $19.9M | Buy |
1,038,451
+317,405
| +44% | +$4.22M | 0.01% | 1274 |
|
|
2021
Q2 | $7.1M | Buy |
721,046
+249,867
| +53% | +$2.27M | ﹤0.01% | 2068 |
|
|
2021
Q1 | $4.63M | Buy |
471,179
+75,987
| +19% | +$626K | ﹤0.01% | 2203 |
|
|
2020
Q4 | $1.76M | Buy |
395,192
+8,939
| +2% | +$40.5K | ﹤0.01% | 2573 |
|
|
2020
Q3 | $1.67M | Buy |
386,253
+40,713
| +12% | +$290K | ﹤0.01% | 2471 |
|
|
2020
Q2 | $3.06M | Buy |
345,540
+52,953
| +18% | +$268K | ﹤0.01% | 2149 |
|
|
2020
Q1 | $1.03M | Buy |
292,587
+2,398
| +0.8% | +$11.1K | ﹤0.01% | 2502 |
|
|
2019
Q4 | $1.66M | Sell |
290,189
-9,666
| -3% | -$51.7K | ﹤0.01% | 2499 |
|
|
2019
Q3 | $1.07M | Buy |
299,855
+56,971
| +23% | +$221K | ﹤0.01% | 2674 |
|
|
2019
Q2 | $969K | Buy |
+242,884
| New | +$1.41M | ﹤0.01% | 2756 |
|
|
2014
Q4 | – | Sell |
-2,184
| Closed | -$31K | – | 1630 |
|
|
2014
Q3 | $31K | Hold |
2,184
| – | – | ﹤0.01% | 1571 |
|
|
2014
Q2 | $35K | Hold |
2,184
| – | – | ﹤0.01% | 1582 |
|
|
2014
Q1 | $39K | Hold |
2,184
| – | – | ﹤0.01% | 1570 |
|
|
2013
Q4 | $43K | Buy |
2,184
+770
| +54% | +$11.3K | ﹤0.01% | 1549 |
|
|
2013
Q3 | $17K | Buy |
1,414
+59
| +4% | +$742 | ﹤0.01% | 1466 |
|
|
2013
Q2 | $15K | Buy |
+1,355
| New | +$28.5K | ﹤0.01% | 1521 |
|
Other funds holding DVAX
Nuveen's DVAX Position: Q1 2026 in Review
Nuveen sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 1,910,588 shares — an estimated $29.4M sold.
Nuveen first reported a position in DVAX in Q2 2013 and held it in 33 quarters. The position peaked at $29.4M in Q4 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.
- Nuveen reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
- Nuveen sold 1,910,588 Dynavax Technologies shares in Q1 2026, an estimated $29.4M.
- Nuveen first reported a position in Dynavax Technologies in Q2 2013 and held it in 33 quarters.
- Nuveen's Dynavax Technologies position peaked at $29.4M in Q4 2025.
- 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.
Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.